Kamal Kumar Ray

Kamal Kumar Ray

Active Director Director DIN 08213252
DIN 08213252 First appointment Sep 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Sep 2018
Shareholding value •••• Premium profile

About Kamal Kumar Ray

Data last updated:

Kamal Kumar Ray is a Director at Cts Clinical Trial Services India Private Limited (since 2018) and Director at Mydoux Technologies Private Limited (since 2018). The companies operate in Healthcare and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹64.3 Lakh; the largest is Cts Clinical Trial Services India Private Limited at ₹62 Lakh (FY 2017).

DIN 08213252
Primary Designation Director
Industry Healthcare
First Appointment 03 Sep 2018
Oldest Company Age 11 yrs
Largest company Cts Clinical Trial Services India Private Limited · ₹62 Lakh (FY 2017)
Combined revenue ₹64.3 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Sep 20182015₹62 Lakh (FY 2017)Active
Mydoux Technologies Private Limited U72200DL2014PTC273751
Director03 Sep 20182014₹2.3 Lakh (FY 2017)Active

Board colleagues of Kamal Kumar Ray

Directorship timeline

Open interactive timeline →
Mydoux Technologies Private Limited
Cts Clinical Trial Services India Private Limited
Premium access

Shareholding and investment profile for Kamal Kumar Ray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamal Kumar Ray

Kamal Kumar Ray currently holds 2 directorships: Cts Clinical Trial Services India Private Limited (Director, since 03 Sep 2018, revenue ₹62 Lakh (FY 2017)); Mydoux Technologies Private Limited (Director, since 03 Sep 2018, revenue ₹2.3 Lakh (FY 2017)).

Kamal Kumar Ray was first appointed on 03 Sep 2018 as Director at Cts Clinical Trial Services India Private Limited.

The 2 current companies of Kamal Kumar Ray that report revenue have a combined latest revenue of ₹64.3 Lakh: Cts Clinical Trial Services India Private Limited ₹62 Lakh (FY 2017); Mydoux Technologies Private Limited ₹2.3 Lakh (FY 2017).

The current boards of Kamal Kumar Ray's companies include Devesh Kumar (Cts Clinical Trial Services India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available